[Selection of the optimal device-aided therapy in Parkinson's disease].

IF 0.6
Norbert Kovács, Zsuzsanna Aschermann, Annamária Juhász, Márk Harmat, Dávid Pintér, József Janszky
{"title":"[Selection of the optimal device-aided therapy in Parkinson's disease].","authors":"Norbert Kovács,&nbsp;Zsuzsanna Aschermann,&nbsp;Annamária Juhász,&nbsp;Márk Harmat,&nbsp;Dávid Pintér,&nbsp;József Janszky","doi":"10.18071/isz.72.0005","DOIUrl":null,"url":null,"abstract":"<p><p>For the treatment of advanced Parkinson's disease the deep brain stimulation (DBS) and the levodopa/carbidopa intestinal gel (LCIG) therapies are available in Hungary. Although they may have similar impact on the health-related quality of life and disabilities associated with the disease, they have different indications, and inclusion- and exclusion criteria. Consequently, the patient population treated with DBS and LCIG may be different. In the present review, the authors try to help the process of selection of the optimal device-aided therapy for the patients with advanced Parkinson's disease.</p>","PeriodicalId":520642,"journal":{"name":"Ideggyogyaszati szemle","volume":" ","pages":"5-11"},"PeriodicalIF":0.6000,"publicationDate":"2019-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ideggyogyaszati szemle","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18071/isz.72.0005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

For the treatment of advanced Parkinson's disease the deep brain stimulation (DBS) and the levodopa/carbidopa intestinal gel (LCIG) therapies are available in Hungary. Although they may have similar impact on the health-related quality of life and disabilities associated with the disease, they have different indications, and inclusion- and exclusion criteria. Consequently, the patient population treated with DBS and LCIG may be different. In the present review, the authors try to help the process of selection of the optimal device-aided therapy for the patients with advanced Parkinson's disease.

[帕金森病最佳器械辅助治疗的选择]。
对于晚期帕金森病的治疗,匈牙利提供深部脑刺激(DBS)和左旋多巴/卡比多巴肠道凝胶(LCIG)疗法。虽然它们可能对与健康有关的生活质量和与疾病相关的残疾产生类似的影响,但它们具有不同的适应症以及纳入和排除标准。因此,接受DBS和LCIG治疗的患者群体可能不同。在本综述中,作者试图帮助晚期帕金森病患者选择最佳设备辅助治疗的过程。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书